3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Advanced Solid Tumor
30
Mesothelioma
20
Solid Tumor
18
Mesothelioma, Malignant
18
Advanced Solid Tumors
18
Solid Tumors
16
Solid Tumor, Adult
11
Melanoma
10
Carcinoma, Non-Small-Cell Lung
10
Ovarian Neoplasms
8
Colorectal Neoplasms
8
Retinoblastoma
7
Carcinoma, Renal Cell
7
Uterine Cervical Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Lung Neoplasms
6
Cholangiocarcinoma
6
Advanced Malignant Solid Neoplasm
6
Triple Negative Breast Neoplasms
5
Sarcoma
5
Stomach Neoplasms
4
Pancreatic Neoplasms
4
Malignant Solid Neoplasm
4
Esophageal Neoplasms
4
Advanced or Metastatic Solid Tumors
4
Small Cell Lung Carcinoma
3
Neoplasms
3
Malignant Solid Tumor
3
Locally Advanced or Metastatic Solid Tumors
3
Hematopoietic and Lymphatic System Neoplasm
3
Interventions
spartalizumab
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Refractory or Recurrent Solid Tumor
×
Other solid neoplasm
×
Clear all
NCT05210413
2026-01-15
SPARTO
University Hospital, Bordeaux
Phase 1/2
Active not recruiting
80 enrolled